Evidence map›Paper›PMID 26888973›Full record

ReviewJournal of diabetes science and technology2016

Current and Next Generation Portable Screening Devices for Diabetic Retinopathy.

J Morgan Micheletti, Andrew M Hendrick, Farah N Khan, David C Ziemer, Francisco J Pasquel

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of diabetes science and technology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. [Smartphone-based fundus imaging: applications and adapters].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2022
    Review
  12. Ophthalmology Going Greener: A Narrative Review.Ophthalmology and therapy · 2021
    Review
  13. Review
  14. Review
  15. Wide field of view handheld smart fundus camera for telemedicine applications.Journal of medical imaging (Bellingham, Wash.) · 2021
    Article
  16. Article
  17. Developing a pediatric ophthalmology telemedicine program in the COVID-19 crisis.Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus · 2020
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

J Morgan MichelettiDepartment of Ophthalmology, Emory University School of Medicine, Atlanta, GA, USA.
Andrew M HendrickDepartment of Ophthalmology, Emory University School of Medicine, Atlanta, GA, USA.
Farah N KhanDivision of Endocrinology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
David C ZiemerDivision of Endocrinology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Francisco J PasquelDivision of Endocrinology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA fpasque@emory.edu.
Emory University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic retinopathy (DR) is the leading cause of legal blindness in the United States, and with the growing epidemic of diabetes, a global increase in the incidence of DR is inevitable, so it is of utmost importance to identify the most cost-effective tools for DR screening. Emerging technology may provide advancements to offset the burden of care, simplify the process, and provide financially responsible methods to safely and effectively optimize care for patients with diabetes mellitus (DM). We review here currently available technology, both in production and under development, for DR screening. Preliminary results of smartphone-based devices, "all-in-one" devices, and alternative technologies are encouraging, but are largely pending verification of utility when used by nonophthalmic personnel. Further research comparing these devices to current nonportable telemedicine strategies and clinical fundus examination is necessary to validate these techniques and to potentially overcome the poor compliance around the globe of current strategies for DR screening.

Indexed as

Diabetic RetinopathyDiagnostic Techniques, OphthalmologicalFemaleHumansMaleMass ScreeningTelemedicinediabetic retinopathyretinascreeningsmartphonetelemedicine

Identifiers

PMID26888973
PMCPMC4773980
OpenAlexW2290571649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.